BILLERICA, Mass.--(BUSINESS WIRE)--
Bruker today announces the appointment of Dr. René Lenggenhager as
President of the Bruker BioSpin Group, effective November 1st,
2015. René has over 25 years of management experience in international
high-tech companies and in the scientific instruments industry, where
his responsibilities have included general management with P&L
responsibility for a global business, marketing, R&D and global
operations. René has extensive experience with complex transformations,
operational excellence, lean manufacturing, marketing and value selling.
Moreover, René has a very successful track record in sustainable,
profitable growth with a focus on customers and innovation.
This Smart News Release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20151013005107/en/
René Lenggenhager, BioSpin, Mettler Toledo, Bruker, analytical instruments, analytical solutions (Photo: Business Wire).
Since 2004, Dr. Lenggenhager has served as General Manager for
Laboratory Weighing at METTLER TOLEDO (MTD). From 2000 until 2003, he
was the Head of R&D of Laboratory & Weighing Technologies at MTD.
Previously, he worked at the Siemens Building Technologies SBT Cerberus
Division, at Cerberus AG, at Landis & Gyr AG and at Metrohm AG. René
holds a Ph.D. in physics from the Swiss Federal Institute of Technology
(ETH), Zurich, a Bachelor of Science in electronics from the University
of Applied Sciences NTB, Buchs, and an Executive MBA from University of
St. Gallen, all in Switzerland.
Frank Laukien, President and CEO of Bruker Corporation, said: “I am very
pleased to welcome René to Bruker. His success in our industry, his
broad technical background, and his passion for innovation and customers
are impressive. His outstanding track record with operational
excellence, profitable growth and margin enhancement make René a
compelling Group President to lead Bruker BioSpin to the next level.”
Dr. René Lenggenhager commented: “Bruker has a strong reputation for
excellence in the customer community, with high-performance instruments
and high-value analytical solutions. Bruker BioSpin is making progress
with its transformation and recent new product launches, and I am
excited to join this creative team to drive profitable growth and value
for our customers and shareholders. I am committed to business success
and to providing the best solutions to make our customers successful,
and to develop new applications that will improve the quality of human
life.”
About Bruker Corporation (NASDAQ: BRKR)
For more than 50 years, Bruker has enabled scientists to make
breakthrough discoveries and develop new applications that improve the
quality of human life. Bruker’s high-performance scientific research
instruments and high-value analytical solutions enable scientists to
explore life and materials at molecular, cellular and microscopic
levels. In close cooperation with our customers, Bruker is enabling
innovation, productivity and customer success in life science molecular
research, in applied and pharma applications, in microscopy,
nano-analysis and industrial applications, as well as in cell biology,
preclinical imaging, clinical research, microbiology and molecular
diagnostics.
For more information, please visit: www.bruker.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20151013005107/en/
Source: Bruker Corporation